Citations

Showing 10 of 107969 citations.

Pomalidomide alone or in combination with low-dose dexamethasone in relapsed and refractory multiple myeloma: a randomized phase 2 study
Richardson, Paul G. , Vij, Ravi , Chen, Christine , Jakubowiak, Andrzej , Song, Kevin , Belch, Andrew , Shustik, Chaim, Lentzsch, Suzanne , Lacy, Martha Q. , Matous, Jeffrey, Vesole, David H. , Chen, Min , Zaki, Mohamed H. , Jacques, Christian , Yu, Zhinuan, Richardson, Paul Gerard Guy , Siegel, David S. , Hofmeister, Craig C. , Baz, Rachid , Jagannath, Sundar , Lonial, Sagar , Bahlis, Nizar Jacques , Raje, Noopur , Mıkhael, Joseph , Anderson, Kenneth C.

Mayo Clinic

Blood | January 13, 2014 | Volume: 123 | Issue: 12 | Pages: 1826-1832

10.1182/blood-2013-11-538835 | PMID 24421329 Get It

Key Points Pomalidomide plus low-dose dexamethasone significantly improved PFS vs pomalidomide alone in relapsed and refractory multiple myeloma. Pomalidomide plus low-dose dexamethasone is an important new treatment option for RRMM patients who have received multiple prior therapies.
Anatomía microscópica del hígado
Krishna, Murli

Mayo Clinic

Clinical Liver Disease | January 13, 2014 | Volume: 2 | Issue: S5 | Pages: 109-112

10.1002/cld.287 | PMID 31333838 Get It

Trasplante hepático y enfermedad hepática por hígado graso no alcohólico
Watt, Kymberly D.

Mayo Clinic

Clinical Liver Disease | January 13, 2014 | Volume: 2 | Issue: S5 | Pages: 106-108

10.1002/cld.286 | PMID 31333837 Get It

Genetic and biochemical analyses in dyslipidemic patients undergoing LDL apheresis
Saenger, Amy K., Train, Laura, Kotzer, Katrina E. , Lagerstedt, Susan A., Hornseth, Jean M, Basu, Ananda, Baudhuin, Linnea M. , Donato, Leslie J. , Winters, Jeffrey L.

Mayo Clinic

Journal of Clinical Apheresis | January 13, 2014 | Volume: 29 | Issue: 5 | Pages: 256-265

10.1002/jca.21317 | PMID 24420163 Get It

Faculty Opinions recommendation of Delayed hemolysis after treatment with parenteral artesunate in African children with severe malaria--a double-center prospective study.
Fischer, Philip R.

Mayo Clinic

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature | January 13, 2014 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.3410/f.718219696.793489384 Get It

CALR mutation studies in chronic neutrophilic leukemia
Elliott, Michelle A. , Pardanani, Animesh , Tefferi, Ayalew , Lasho, Terra L.

Mayo Clinic

American Journal of Hematology | January 13, 2014 | Volume: 89 | Issue: 4 | Pages: 450-450

10.1002/ajh.23665 | PMID 24421250 Get It

Using Item Response Theory to Model Multiple Phenotypes and Their Joint Heritability in Family Data
Fragoso, Tiago M., Giolo, Suely Ruiz , Pereira, Alexandre C. , Andrade, Mariza de , Soler, Júlia Maria Pavan , de Andrade, Mariza

Mayo Clinic

Genetic Epidemiology | January 12, 2014 | Volume: 38 | Issue: 2 | Pages: 152-161

10.1002/gepi.21784 | PMID 24415554 Get It

ABSTRACTMany important complex diseases are composed of a series of phenotypes, which makes the disease diagnosis and its genetic dissection difficult. The standard procedures to determine heritability in such complex diseases are either applied for single phenotype analyses or to compare findings across phenotypes or multidimensional reduction procedures, such as principal components analysis using all phenotypes. However each method has its own problems and the challenges are even more complex for extended family data and categorical phenotypes. In this paper, we propose a methodology to determine a scale for complex outcomes involving multiple categorical phenotypes in extended pedigrees using item response theory (IRT) models that take all categorical phenotypes into account, allowing informative comparison among individuals. An advantage of the IRT framework is that a straightforward joint heritability parameter can be estimated for categorical phenotypes. Furthermore, our methodology allows many possible extensions such as the inclusion of covariates and multiple variance components. We use Markov Chain Monte Carlo algorithm for the parameter estimation and validate our method through simulated data. As an application we consider the metabolic syndrome as the multiple phenotype disease using data from the Baependi Heart Study consisting of 1,696 individuals in 95 families. We adjust IRT models without covariates and include age and age squared as covariates. The results showed that adjusting for covariates yields a higher joint heritability () than without co variates () indicating that the covariates absorbed some of the error variance.
Organ Donation and Palliative Care: Can Palliative Care Make a Difference?
Prommer, Eric

Mayo Clinic

Journal of Palliative Medicine | January 11, 2014 | Volume: 17 | Issue: 3 | Pages: 368-371

10.1089/jpm.2013.0375 | PMID 24410368 Get It

The two faces of neuromyelitis optica
Weinshenker, Brian G. , Wingerchuk, Dean M. , Weinshenker, Brian G

Mayo Clinic

Neurology | January 11, 2014 | Volume: 82 | Issue: 6 | Pages: 466-467

10.1212/wnl.0000000000000114 | PMID 24415570 Get It

Why are sex and gender important to basic physiology and translational and individualized medicine?
Miller, Virginia M.

Mayo Clinic

American Journal of Physiology-Heart and Circulatory Physiology | January 11, 2014 | Volume: 306 | Issue: 6 | Pages: H781-H788

10.1152/ajpheart.00994.2013 | PMID 24414073 Get It

Sex refers to biological differences between men and women. Although sex is a fundamental aspect of human physiology that splits the population in two approximately equal halves, this essential biological variable is rarely considered in the design of basic physiological studies, in translating findings from basic science to clinical research, or in developing personalized medical strategies. Contrary to sex, gender refers to social and cultural factors related to being a man or a woman in a particular historical and cultural context. Unfortunately, gender is often used incorrectly by scientists and clinical investigators as synonymous with sex. This article clarifies the definition of sex and gender and reviews evidence showing how sex and gender interact with each other to influence etiology, presentation of disease, and treatment outcomes. In addition, strategies to improve the inclusion of female and male human beings in preclinical and clinical studies will be presented, and the importance of embedding concepts of sex and gender into postgraduate and medical curricula will be discussed. Also, provided is a list of resources for educators. In the history of medical concepts, physiologists have provided pivotal contributions to understanding health and disease processes. In the future, physiologists should provide the evidence for advancing personalized medicine and for reducing sex and gender disparities in health care.